Top Markets
#1 NKN NKN +185.61%
#2 Black Phoenix Black Phoenix +99.33%
#3 Liquid Mercury Liquid Mercury +33.08%
#4 Codatta Codatta +28.59%
#5 Saakuru Saakuru +25.06%
#6 Particle Network Particle Network +17.23%
#7 Bedrock Bedrock +15.78%
#8 StakeStone StakeStone +14.95%
#9 Janction Janction +14.79%
#10 Arcblock Arcblock +14.20%
Coin of the day
NKN NKN
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
AbbVie Inc. AbbVie Inc.

AbbVie Inc.

ABBV
Classement en actions #30
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the... AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Prix de l'action
$208.57
Capitalisation boursière
$368.78B
Changement (1 jour)
0.68%
Changement (1 an)
3.61%
Pays
US
Échange AbbVie Inc. (ABBV)

Catégorie

Healthcare
Nombre d'actions en circulation pour AbbVie Inc. (ABBV)
Nombre d'actions en circulation au December 2025: 1.78B
Selon les derniers rapports financiers et le cours de l'action de AbbVie Inc., le nombre actuel d'actions en circulation est de 1.78B. À la fin de December 2024, l'entreprise avait 1.77B actions en circulation. Le nombre d'actions en circulation est généralement affecté par les divisions d'actions et les rachats d'actions.
Historique des actions en circulation de AbbVie Inc. (ABBV) de 2009 à 2026
Actions en circulation à la fin de chaque année
Année Actions en circulation Changez
2026 (TTM) 1.78B -0.57%
2025 1.79B 1.23%
2024 1.77B 0.06%
2023 1.77B -0.17%
2022 1.77B 0.06%
2021 1.77B 6.18%
2020 1.67B 12.56%
2019 1.48B -3.89%
2018 1.54B -3.45%
2017 1.60B -1.60%
2016 1.62B -0.18%
2015 1.63B 1.88%
2014 1.60B 0.38%
2013 1.59B 0.76%
2012 1.58B -2.41%
2011 1.62B 0.00%
2010 1.62B 0.00%
2009 1.62B 0.00%
Actions en circulation pour des entreprises similaires ou concurrentes
Entreprise Actions en circulation Différence Pays
Eli Lilly Eli Lilly
Eli Lilly
LLY.US
 898.00M -49.56%
US
AstraZeneca PLC AstraZeneca PLC
AstraZeneca PLC
AZN.US
 3.10B 74.12%
GB
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 2.43B 36.41%
US
Novartis AG Novartis AG
Novartis AG
NVS.US
 1.91B 7.45%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 2.49B 39.85%
US